Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-26T19:42:05.093Z Has data issue: false hasContentIssue false

Outcome of facial physiotherapy in patients with prolonged idiopathic facial palsy

Published online by Cambridge University Press:  18 March 2015

G J Watson*
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth Hospital, Birmingham, UK
S Glover
Affiliation:
Department of Physiotherapy, Queen Elizabeth Hospital, Birmingham, UK
S Allen
Affiliation:
Department of Physiotherapy, Queen Elizabeth Hospital, Birmingham, UK
R M Irving
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth Hospital, Birmingham, UK
*
Address for correspondence: Mr Glen J Watson, Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth Hospital, Birmingham, UK Fax: +44 121 371 4521 E-mail: glen_watson74@yahoo.co.uk

Abstract

Objective:

This study investigated whether patients who remain symptomatic more than a year following idiopathic facial paralysis gain benefit from tailored facial physiotherapy.

Methods:

A two-year retrospective review was conducted of all symptomatic patients. Data collected included: age, gender, duration of symptoms, Sunnybrook facial grading system scores pre-treatment and at last visit, and duration of treatment.

Results:

The study comprised 22 patients (with a mean age of 50.5 years (range, 22–75 years)) who had been symptomatic for more than a year following idiopathic facial paralysis. The mean duration of symptoms was 45 months (range, 12–240 months). The mean duration of follow up was 10.4 months (range, 2–36 months). Prior to treatment, the mean Sunnybrook facial grading system score was 59 (standard deviation = 3.5); this had increased to 83 (standard deviation = 2.7) at the last visit, with an average improvement in score of 23 (standard deviation = 2.9). This increase was significant (p < 0.001).

Conclusion:

Tailored facial therapy can improve facial grading scores in patients who remain symptomatic for prolonged periods.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Gronseth, GS, Paduga, R. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012;79:2209–13Google Scholar
2Salinas, RA, Alvarez, G, Daly, F, Ferreira, J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2010;(3):CD001942CrossRefGoogle ScholarPubMed
3Sullivan, FM, Swan, IR, Donnan, PT, Morrison, JM, Smith, BH, McKinstry, B et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007;357:1598–607CrossRefGoogle ScholarPubMed
4Baugh, RF, Basura, GJ, Ishii, LE, Schwartz, SR, Drumheller, CM, Burkholder, R et al. Clinical practice guideline: Bell's palsy executive summary. Otolaryngol Head Neck Surg 2013;149:656–63CrossRefGoogle ScholarPubMed
5Ishii, L, Godoy, A, Encarnacion, CO, Byrne, PJ, Boahene, KD, Ishii, M. Not just another face in the crowd: society's perceptions of facial paralysis. Laryngoscope 2012;122:533–8Google Scholar
6Teixeira, LJ, Valbuza, JS, Prado, GF. Physical therapy for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2011;(12):CD006283Google Scholar
7Lindsay, RW, Robinson, M, Hadlock, TA. Comprehensive facial rehabilitation improves function in people with facial paralysis: a 5-year experience at the Massachusetts Eye and Ear Infirmary. Phys Ther 2010;90:391–7CrossRefGoogle ScholarPubMed